@article{2e17f8c8d7f04bbca41d68b32bb6ed04,
title = "Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance",
abstract = "Novelty and Impact Statement: Our findings suggest that soluble folate receptor (sFR) could be used in both the initial diagnosis and surveillance of patients with ovarian cancer. Our cohort constitutes one of the largest comparison groups for sFR analyzed so far. We have defined the background level of sFR using healthy volunteers. This is also the first study to prospectively follow patients in the surveillance setting to concurrently identify differential changes in tumor markers CA-125 and sFR.",
keywords = "biomarkers, gynecologic oncology, translational research",
author = "Batoul Farran and Samet Albayrak and Judith Abrams and Tainsky, {Michael A.} and Levin, {Nancy K.} and Robert Morris and Matherly, {Larry H.} and Manohar Ratnam and Ira Winer",
note = "Funding Information: Work for this project was supported, in part, by the Gail Purtan Ovarian Cancer Research Fund and the Jacqueline E. Bayley Fund for Ovarian Cancer Research. Dr. Matherly is supported by the Eunice and Milton Ring Endowed Chair for Cancer Research. Nancy Levin was supported by NIH grant R21‐CA187278 for the bio‐banking component of this study. Dr. Abrams and the Biostatistics Core is supported, in part, by NIH Center grant P30 CA022453 to the Karmanos Cancer Institute at Wayne State University. Funding Information: National Institutes of Health, Grant/ Award Number: P30 CA022453 and R21- CA187278 ; Gail Purtan Ovarian Cancer Research Fund; Jacqueline E. Bayley Fund for Ovarian Cancer Research Publisher Copyright: {\textcopyright} 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.",
year = "2019",
month = mar,
doi = "10.1002/cam4.1944",
language = "English (US)",
volume = "8",
pages = "920--927",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "3",
}
